|
|
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a−12 under the Exchange Act (17 CFR 240.14a−12)
|
|
Pre−commencement communications pursuant to Rule 14d−2(b) under the Exchange Act (17 CFR 240.14d−2(b))
|
|
Pre−commencement communications pursuant to Rule 13e−4(c) under the Exchange Act (17 CFR 240.13e− 4(c))
|
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
||
|
|
|
|||
|
|
| Item 2.02 |
Results of Operations and Financial Condition.
|
| Item 7.01 |
Regulation FD Disclosure.
|
| Item 9.01 |
Financial Statements and Exhibits.
|
|
Exhibit No.
|
Description
|
|
Press Release of Advent Technologies Holdings, Inc. dated August 12, 2021.
|
|
Dated: August 12, 2021
|
||
|
Advent Technologies Holdings, Inc.
|
||
|
By:
|
/s/ Vassilios Gregoriou
|
|
|
Name:
|
Vassilios Gregoriou
|
|
|
Title:
|
Chairman and Chief Executive Officer
|
|
| • |
Q2 Revenue up 400% versus prior year on increased customer demand for Advent product offerings and acquisition of UltraCell
|
| • |
Net loss of $(3.14) million and adjusted net loss of $(6.79) million excluding warrant valuation adjustment
|
| • |
Company holds cash reserves of $116.11 million
|
| • |
Strong market interest reflected in high level of commercial activity
|
| • |
Total revenue of $1.00 million, a 400% year-over-year increase, the result of increased customer demand for Advent’s products across the board and the acquisition of UltraCell.
|
| • |
Gross Profit of $0.33 million, a year-over-year increase of $0.35 million primarily due to higher revenues.
|
| • |
Operating expenses were $7.2 million, primarily related to increased staffing and costs to operate as a public company, as well as our cooperative research and development agreement (“CRADA”)
with the Department of Energy which we announced in March 2021.
|
| • |
Net loss and adjusted net loss were $(3.14) million and $(6.79) million, respectively. Adjusted net loss excludes the impact from the change in the fair value of outstanding warrants.
|
| • |
Net loss per share was $(0.07).
|
| • |
Cash reserves were $116.11 million on June 30, 2021, a decrease of $8.87 million from March 31, 2021, driven primarily by the use of cash for operating and capital expenses and a $2 million
payment to complete the acquisition of UltraCell.
|
|
(in Millions of US dollars, except per share data)
|
Three Months Ended June 30,
|
|||||||||||
|
2021
|
2020
|
$ Change
|
||||||||||
|
Revenue, net
|
$
|
1.00
|
$
|
0.20
|
$
|
0.80
|
||||||
|
Gross Profit
|
$
|
0.33
|
$
|
(0.02
|
)
|
$
|
0.35
|
|||||
|
Gross Margin (%)
|
33
|
%
|
(9
|
)%
|
||||||||
|
Operating Income/(Loss)
|
$
|
(6.79
|
)
|
$
|
(0.41
|
)
|
$
|
(6.38
|
)
|
|||
|
Net Income/(Loss)
|
$
|
(3.14
|
)
|
$
|
(0.31
|
)
|
$
|
(2.83
|
)
|
|||
|
Net Income/(Loss) Per Share
|
$
|
(0.07
|
)
|
$
|
(0.02
|
)
|
$
|
(0.05
|
)
|
|||
|
Non-GAAP Financial Measures
|
||||||||||||
|
Adjusted EBITDA
|
$
|
(6.80
|
)
|
$
|
(0.40
|
)
|
$
|
(6.40
|
)
|
|||
|
Adjusted Net
Income/(Loss) - Excl Warrant Adjustment
|
$
|
(6.79
|
)
|
$
|
(0.31
|
)
|
$
|
(6.48
|
)
|
|||
|
Cash and Cash Equivalents
|
$
|
116.11
|
||||||||||
| • |
Acquisition of the Fuel Cell Systems Businesses, Serenergy
and fischer eco solutions GmbH, from fischer Group: On June 25, 2021, Advent announced that the Company entered into an agreement to acquire the fuel cell systems businesses,
Serenergy and fischer eco solutions GmbH, from fischer Group. Serenergy, based in Denmark and the Philippines, is a leading manufacturer of HT-PEM fuel cell systems globally, with thousands shipped around the globe during its 15-year
operation. fischer eco solutions (“FES”), based in Germany, provides fuel-cell stack assembly and testing as well as the production of critical fuel cell components, including membrane electrode assemblies (“MEAs”), bipolar plates, and
reformers. FES operates a facility on fischer Group’s campus in Achern, Germany, and that facility will be leased to Advent upon closing of the deal. The transaction is expected to accelerate the implementation of Advent’s business plan
and to expand Advent’s growing revenue base in full fuel cell stacks and systems. The transaction is expected to close in the third quarter of 2021.
|
| • |
Expanding Global Footprint Through Acquisitions: With the addition of Serenergy and fischer eco solutions, Advent will expand its geographic footprint by three countries in Europe and southeast Asia and will add 92 employees to its
growing team. The deal will bring together some of the leading minds in the high-temperature fuel cell space and will further build Advent’s platform to meet the rapidly increasing demand for clean energy worldwide. This transaction fully
aligns with Advent’s “Any Fuel. Anywhere.” option and this, together with the previously completed UltraCell acquisition, makes Advent a true global leader in the remote and off-grid power market for fuel cell production, with mobility
and aviation products on the horizon as well.
|
| • |
Collaboration with the DOE: On March 1, 2021, Advent announced that it had entered into a joint development agreement (the “CRADA”) with the United States Department of
Energy’s (DOE’s) Los Alamos National Laboratory (LANL), Brookhaven National Laboratory (BNL), and National Renewable Energy Laboratory (NREL). Under this CRADA, along with support from the DOE’s Hydrogen and Fuel Cell Technologies
Office (HFTO), Advent’s team of scientists are working closely with its LANL, BNL, and NREL counterparts to develop breakthrough materials to help strengthen U.S. manufacturing in the fuel cell sector and bring high-temperature proton
exchange membrane (HT-PEM) fuel cells to the market. This very important program has continued to progress over recent months, including delivery and testing of samples for key components of next generation HT-PEM materials.
|
| • |
Announced Participation in Major European Hydrogen Project
(IPCEI) “White Dragon” Proposal Submission: On May 19, 2021, Advent announced the national proposal for hydrogen technologies "White Dragon" was submitted by a group of the
largest energy companies in Greece. The proposal sets forth a future vision for the entire hydrogen value chain and a path to expand its role in the Greek energy system’s reduced carbon goals. The objective of the project is to gradually
replace the lignite power plants of Western Macedonia and transition to clean energy production and transmission, with the ultimate goal of fully decarbonizing Greece's energy system. The "White Dragon" project plans to use large-scale
renewable electricity to produce green hydrogen by electrolysis in Western Macedonia. This hydrogen would then be stored and, through Advent’s high-temperature fuel cells, supply all of Greece with clean electricity, green energy and
heat. Further, in July 2021, Advent announced that it had been nominated by the Greek Ministry of Development and Investment to be part of the first wave of IPCEI on Hydrogen and had
also been selected by the Ministry to be the Coordinator of Technology Field 2 dedicated to fuel cells and associated technologies. The company is pleased to be the designated fuel cell partner for an €8 billion project.
|
| • |
Selection of Advent’s Wearable Fuel Cell for the New Contract with U.S. Department of Defense: On June 7, 2021, Advent signed a new contract through its subsidiary, UltraCell, with the U.S. Department of Defense for a wearable fuel cell. Through this contract, Advent will be
focusing on completing the MIL-STD certification of UltraCell’s 50 W Reformed Methanol Wearable Fuel Cell Power System (“Honey Badger”). Honey Badger is designed to integrate with materials already utilized by the U.S. Army and will operate
as a wearable battery that can be functioning “on the move.” As noted previously, Honey Badger was selected by the DoD’s National Defense Center for Energy and Environment (NDCEE) to take part in its 2021 demonstration/validation program.
The Company remains excited about the continued progress of Honey Badger, and partnering with the U.S. Army is a landmark for Advent as its products become a key choice for defense applications.
|
| • |
Announced New Chief Financial Officer: On July 2, 2021, Advent announced that Kevin Brackman joined the Company as its new Chief Financial Officer. He will report to Advent Chairman and CEO Dr. Vasilis Gregoriou. Mr.
Brackman replaces Bill Hunter, who had served as CFO of Advent following its merger in February 2021 with AMCI Acquisition Corp., where he was Chief Executive Officer.
|
|
As of
|
||||||||
|
ASSETS
|
June 30, 2021
(Unaudited)
|
December 31,
2020
|
||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
116,109,057
|
$ | 515,734 | ||||
|
Accounts receivable
|
1,110,825
|
421,059 |
||||||
|
Due from related parties
|
16,153
|
67,781 |
||||||
|
Contract assets
|
435,164
|
85,930 |
||||||
|
Inventories
|
857,671
|
107,939
|
||||||
|
Prepaid expenses and Other current assets
|
2,846,143
|
496,745
|
||||||
|
Total current assets
|
121,375,013
|
1,695,188
|
||||||
|
Non-current assets:
|
||||||||
|
Goodwill and intangibles, net
|
5,207,817
|
- |
||||||
|
Property and equipment, net
|
1,115,176
|
198,737 |
||||||
|
Other non-current assets
|
2,660,939
|
136 |
||||||
|
Total non-current assets
|
8,983,932
|
198,873
|
||||||
|
Total assets
|
$
|
130,358,945
|
$ | 1,894,061 | ||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY/(DEFICIT)
|
||||||||
|
Current liabilities:
|
||||||||
|
Trade and other payables
|
$
|
2,883,325
|
$ | 881,394 | ||||
|
Due to related parties
|
30,000
|
1,114,659
|
||||||
|
Deferred income from grants, current
|
65,180
|
158,819
|
||||||
|
Contract liabilities
|
140,940
|
167,761
|
||||||
|
Other current liabilities
|
331,071
|
904,379
|
||||||
|
Income tax payable
|
191,194
|
201,780
|
||||||
|
Total current liabilities
|
3,641,711
|
3,428,792
|
||||||
|
Non-current liabilities:
|
||||||||
|
Warrant liability
|
19,704,861
|
-
|
||||||
|
Deferred income from grants, non-current
|
176,525
|
182,273
|
||||||
|
Other long-term liabilities
|
182,140
|
76,469
|
||||||
|
Total non-current liabilities
|
20,063,525
|
258,742
|
||||||
|
Total liabilities
|
23,705,236
|
3,687,534
|
||||||
|
Commitments and contingent liabilities
|
-
|
- |
||||||
|
Stockholders’ equity / (deficit)
|
||||||||
|
Common stock ($0.0001 par value per share; Shares authorized: 110,000,000 at June 30, 2021 and
December 31, 2020; Issued and outstanding: 46,128,745 and 25,033,398 at June 30, 2021 and December 31, 2020, respectively)
|
4,613
|
2,503
|
||||||
|
Preferred stock ($0.0001 par value per share; Shares authorized: 1,000,000 at June 30, 2021 and
December 31, 2020; nil issued and outstanding at June 30, 2021 and December 31, 2020
|
-
|
- |
||||||
|
Additional paid-in capital
|
119,964,708
|
10,993,762
|
||||||
|
Accumulated other comprehensive (loss) / income
|
(176,457
|
) |
111,780
|
|||||
|
Accumulated deficit
|
(13,139,155
|
) |
(12,901,518
|
) | ||||
|
Total stockholders’ equity / (deficit)
|
106,653,709
|
(1,793,473
|
) | |||||
|
Total liabilities and stockholders’ equity / (deficit)
|
$
|
130,358,945
|
$
|
1,894,061
|
||||
|
Three months ended June 30,
(Unaudited)
|
Six months ended June 30,
(Unaudited)
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
Revenue, net
|
$
|
1,003,464
|
$
|
200,354
|
$
|
2,492,756
|
$
|
300,620
|
||||||||
|
Cost of revenues
|
(669,352
|
)
|
(217,916
|
)
|
(1,016,695
|
)
|
(283,953
|
)
|
||||||||
|
Gross profit / (loss)
|
334,112
|
(17,562
|
)
|
1,476,061
|
16,667
|
|||||||||||
|
Income from grants
|
85,727
|
54,828
|
124,180
|
143,106
|
||||||||||||
|
Research and development expenses
|
(638,753
|
)
|
-
|
(667,835
|
)
|
(43,633
|
)
|
|||||||||
|
Administrative and selling expenses
|
(6,595,735
|
)
|
(444,129
|
)
|
(14,517,593
|
)
|
(754,434
|
)
|
||||||||
|
Amortization of intangibles
|
29,047
|
-
|
(157,713
|
)
|
-
|
|||||||||||
|
Operating loss
|
(6,785,602
|
)
|
(406,863
|
)
|
(13,742,899
|
)
|
(638,294
|
)
|
||||||||
|
Finance costs
|
(3,139
|
)
|
(514
|
)
|
(13,419
|
)
|
(3,037
|
)
|
||||||||
|
Fair value change of warrant liability
|
3,645,835
|
-
|
13,411,460
|
-
|
||||||||||||
|
Foreign exchange differences, net
|
(10,839
|
)
|
8
|
13,116
|
(18,579
|
)
|
||||||||||
|
Other income / (expenses), net
|
10,435
|
98,351
|
94,105
|
(6,210
|
)
|
|||||||||||
|
Loss before income tax
|
(3,143,311
|
)
|
(309,017
|
)
|
(237,637
|
)
|
(666,120
|
)
|
||||||||
|
Income tax
|
-
|
(3,101
|
)
|
-
|
(3,101
|
)
|
||||||||||
|
Net loss
|
$
|
(3,143,311
|
)
|
$
|
(312,118
|
)
|
$
|
(237,637
|
)
|
$
|
(669,221
|
)
|
||||
|
Net loss per share
|
||||||||||||||||
|
Basic loss per share
|
(0.07
|
)
|
(0.02
|
)
|
(0.01
|
)
|
(0.04
|
)
|
||||||||
|
Basic weighted average number of shares
|
46,126,490
|
18,736,370
|
42,041,473
|
17,623,672
|
||||||||||||
|
Diluted loss per share
|
(0.07
|
)
|
(0.02
|
)
|
(0.01
|
)
|
(0.04
|
)
|
||||||||
|
Diluted weighted average number of shares
|
46,126,490
|
18,736,370
|
42,041,473
|
17,623,672
|
||||||||||||
|
Six months ended June 30,
(Unaudited)
|
||||||||
|
2021
|
2020
|
|||||||
|
Net Cash used in Operating Activities
|
$
|
(16,231,479
|
)
|
$
|
(690,905
|
)
|
||
|
Cash Flows from Investing Activities:
|
||||||||
|
Purchases of property and equipment
|
(947,846
|
)
|
(64,786
|
)
|
||||
|
Advances for the acquisition of property and equipment
|
(2,528,957
|
)
|
-
|
|||||
|
Acquisition of a subsidiary, net of cash acquired
|
(5,922,871
|
)
|
-
|
|||||
|
Net Cash used in Investing Activities
|
$
|
(9,399,674
|
)
|
$
|
(64,786
|
)
|
||
|
Cash Flows from Financing Activities:
|
||||||||
|
Business Combination and PIPE financing, net of issuance costs paid
|
141,120,851
|
-
|
||||||
|
Proceeds of issuance of preferred stock
|
-
|
1,430,005
|
||||||
|
Proceeds from issuance of non-vested stock awards
|
-
|
12,801
|
||||||
|
Repurchase of shares
|
-
|
(34,836
|
)
|
|||||
|
Proceeds of issuance of common stock and paid-in capital from warrants exercise
|
262,177
|
-
|
||||||
|
State loan proceeds
|
117,490
|
-
|
||||||
|
Repayment of convertible promissory notes
|
-
|
(500,000
|
)
|
|||||
|
Net Cash provided by Financing Activities
|
$
|
141,500,518
|
$
|
907,970
|
||||
|
Net increase in cash and cash equivalents
|
$
|
115,869,365
|
$
|
152,279
|
||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(276,042
|
)
|
(4,224
|
)
|
||||
|
Cash and cash equivalents at the beginning of the period
|
515,734
|
1,199,015
|
||||||
|
Cash and cash equivalents at the end of the period
|
$
|
116,109,057
|
$
|
1,347,070
|
||||
|
|
||||||||
|
Supplemental Cash Flow Information
|
||||||||
|
Non-cash Operating Activities:
|
||||||||
|
Recognition of stock grant plan
|
$
|
702,894
|
$
|
176,768
|
||||
|
EBITDA and Adjusted EBITDA
|
Three months ended June 30,
(Unaudited)
|
Six months ended June 30,
(Unaudited)
|
||||||||||||||||||||||
|
(in Millions of US dollars)
|
2021
|
2020
|
$ change
|
2021
|
2020
|
$ change
|
||||||||||||||||||
|
Net loss
|
$
|
(3.14
|
)
|
$
|
(0.31
|
)
|
(2.83
|
)
|
$
|
(0.24
|
)
|
$
|
(0.67
|
)
|
0.43
|
|||||||||
|
Depreciation of property and equipment
|
$
|
0.02
|
$
|
0.01
|
0.01
|
$
|
0.03
|
$
|
0.01
|
0.02
|
||||||||||||||
|
Amortization of intangibles
|
$
|
(0.03
|
)
|
$
|
0.00
|
(0.03
|
)
|
$
|
0.16
|
$
|
0.00
|
0.16
|
||||||||||||
|
Finance costs
|
$
|
0.00
|
$
|
0.00
|
0.00
|
$
|
0.01
|
$
|
0.00
|
0.01
|
||||||||||||||
|
Other income / (expenses), net
|
$
|
(0.01
|
)
|
$
|
(0.10
|
)
|
0.09
|
$
|
(0.09
|
)
|
$
|
0.01
|
(0.10
|
)
|
||||||||||
|
Foreign exchange differences, net
|
$
|
0.01
|
$
|
(0.00
|
)
|
0.01
|
$
|
(0.01
|
)
|
$
|
0.02
|
(0.03
|
)
|
|||||||||||
|
EBITDA
|
$
|
(3.15
|
)
|
$
|
(0.40
|
)
|
(2.75
|
)
|
$
|
(0.14
|
)
|
$
|
(0.63
|
)
|
0.49
|
|||||||||
|
Net change in warrant liability
|
$
|
(3.65
|
)
|
$
|
-
|
(3.65
|
)
|
$
|
(13.41
|
)
|
$
|
-
|
(13.41
|
)
|
||||||||||
|
One-Time Transaction Related Expenses (1)
|
$
|
-
|
$
|
-
|
-
|
$
|
5.87
|
$
|
-
|
5.87
|
||||||||||||||
|
Adjusted EBITDA
|
$
|
(6.80
|
)
|
$
|
(0.40
|
)
|
(6.40
|
)
|
$
|
(7.68
|
)
|
$
|
(0.63
|
)
|
(7.05
|
)
|
||||||||
|
Adjusted Net Loss
|
Three months ended June 30, (Unaudited)
|
Six months ended June 30, (Unaudited)
|
||||||||||||||||||||||
|
(in Millions of US dollars)
|
2021
|
2020
|
$ change
|
2021
|
2020
|
$ change
|
||||||||||||||||||
|
Net loss
|
$
|
(3.14
|
)
|
$
|
(0.31
|
)
|
(2.83
|
)
|
$
|
(0.24
|
)
|
$
|
(0.67
|
)
|
0.43
|
|||||||||
|
One-Time Transaction Related Expenses (1)
|
$
|
-
|
$
|
-
|
-
|
$
|
5.87
|
$
|
-
|
5.87
|
||||||||||||||
|
Net change in warrant liability
|
$
|
(3.65
|
)
|
$
|
-
|
(3.65
|
)
|
$
|
(13.41
|
)
|
$
|
-
|
(13.41
|
)
|
||||||||||
|
Adjusted Net Loss
|
$
|
(6.79
|
)
|
$
|
(0.31
|
)
|
(6.48
|
)
|
$
|
(7.78
|
)
|
$
|
(0.67
|
)
|
(7.11
|
)
|
||||||||